Comparative Study Between Vaginal Natural Progesterone and Oral Dydrogesterone in Prevention of Red Degeneration of Uterine Fibroid in Pregnancy [PDF]
, 2022 Nermeen Mohamed Hefila +3 more
openalex +1 more source
Ultra-low-dose estradiol and dydrogesterone for treatment of vasomotor symptoms in Europe and China.
ClimactericOBJECTIVE Among postmenopausal women, oral, ultra-low-dose continuous combined estradiol (E0.5 mg) plus dydrogesterone (D2.5 mg) reduces vasomotor symptoms (VMS). METHODS This study was a post hoc analysis of data from two phase 3, double-blind studies.
Qi Yu +8 more
semanticscholar +1 more source
Role of Progesterone Receptor Polymorphisms in the Recurrent Spontaneous Abortions: Indian Case [PDF]
, 2010 Background: We attempt to ascertain if the 3 linked single nucleotide polymorphisms (SNPs) of the Progesterone ...
Alla G. Reddy +9 more
core +3 more sources
International Journal of Reproduction Contraception Obstetrics and GynecologyInfertility affects millions globally, with significant prevalence in India due to conditions like endometriosis and polycystic ovarian syndrome (PCOS).
A. Patki +12 more
semanticscholar +1 more source
The Effect of Dydrogesterone on Premenstrual Symptoms:A Double-blind, Randomized, Placebo-controlled Study in General Practice [PDF]
, 1988 Vibeke Hoffmann +4 more
openalex +1 more source
CLINICAL-PHARMACOLOGICAL APECTS OF THE USE OF DYDROGESTERONE IN PREGNANCY MAINTENANCE
Акушерство, гинекология и репродукция, 2016 Dydrogesterone is a gestagen with proven pregnancy maintaining efficacy, which has been in common medical practice for more than 15 years in the Russian Federation and for more than 45 years outside of Russia.
E. V. Shikh
doaj
Objective assessment of hormonal therapy value as the risk minimization method associated with the sex hormone deficit [PDF]
Гинекология, 2014 Modern views on the issue of menopausal hormone therapy based on updated recommendations of the International Menopause Society 2013 are reviewed in the following article as well as the basic principles of hormone therapy in peri - and postmenopausal ...
N A Sheshukova, O V Bolshakova
doaj
A systematic review of dydrogesterone for the treatment of recurrent miscarriage
Gynecological Endocrinology, 2015 The objective of this systematic review was to assesses whether the orally acting progestagen, dydrogesterone lowers the incidence of subsequent miscarriage in women with recurrent miscarriage. A computerized search was performed in Medline, Embase and Ovid Medline for original reports with the product name "Duphaston" or "dydrogesterone" and limited ...
openaire +2 more sources
Progesteron’s agonist Dydrogesteron in the treatment of the miscarriage
Journal of obstetrics and women's diseases, 2000 The study was earned out to investigate effect of Progesterone 's agonist Dydrogesterone in the treatment оf the miscarriage. Thus, it was seen that Dydrogesterone 's treatment (10 mg/daily per os) zvas more effective than Progesterone for prophylactic miscarriage.
A. V. Ivanova +3 more
openaire +3 more sources
Uteroplacental circulation in early pregnancy complicated by threatened abortion supplemented with vaginal micronized progesterone or oral dydrogesterone [PDF]
, 2006 Krzysztof Czajkowski +5 more
openalex +1 more source